Answers are grounded in this paper and cite their sources.
Experiencing intimate partner violence (IPV) can decrease access to HIV pre-exposure prophylaxis (PrEP) among Black cisgender women. Yet, few trauma-informed implementation strategies in PrEP-prescribing healthcare settings have been developed to address IPV and HIV prevention. Leveraging implementation science frameworks, this study aimed to develop, implement, and evaluate a trauma-informed PrEP Implementation Toolkit for clinical staff in Mississippi. Using the PRISM/RE-AIM framework, a hybrid effectiveness-implementation type 3 study was conducted between October 2020 and October 2023 with HIV clinical staff in Mississippi. Serial semi-structured interviews were conducted with 10 staff before, during, and after Toolkit rollout. A longitudinal qualitative approach was used to analyze how qualitative themes changed over time. The trauma-informed PrEP Implementation Toolkit was executed in a nonrandomized waitlist control, group-based staff educational intervention in two community clinics in eight-month intervals. Seventeen staff across the two clinics participated in four 1-hour training sessions. Efficacy of the Toolkit was tested using pre-post-post surveys, and generalized estimating equations assessed changes in feasibility and appropriateness. Despite having a clinic protocol, staff observed gaps in comprehensive IPV screening and consistent staff roles after Toolkit rollout. Staff valued the training integrating IPV and HIV prevention for Black women, but implementation was constrained by pandemic-related conditions. Compared with the formative period, staff members’ perceived appropriateness of IPV screening increased during implementation (B = 1.76, 95% CI [0.19, 3.88], p = .02), and perceived appropriateness of the training increased during adoption (B = 1.22, 95% CI [0.02, 2.42], p = .04). Trauma-informed PrEP implementation programs may have the potential to address IPV and PrEP engagement in clinics. Solutions are needed to minimize the impacts of public health crises during implementation. Overall, this study could have implications for program implementation in U.S. priority jurisdictions with high HIV incidence among Black cisgender women. Clinicaltrials.gov ID: NCT05139069.
No takes yet. Share an insight, caveat, or question.
Willie et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: